Kirk Huntsman, CEO of Vivos Therapeutics, gives hope for sleep apnea, a condition that an estimated 39 million US adults suffer through, and how taking charge of our health quite literally starts with our breathing. 

All that, plus the Flava of the Week about F45 teaming up to add GLP-1 medications to its on-demand fitness and nutrition tools. How does it work, and why should we cheer on similar offerings that lead consumers down the path to better health? 

This show is produced by the Consumer-First Health Group, the community for consumer-centered health enthusiasts. (#398)

See omnystudio.com/listener for privacy information.